Leigh Vosseller net worth and biography

Leigh Vosseller Biography and Net Worth

Leigh Vosseller has served as our Executive Vice President, Chief Financial Officer and Treasurer since June 2018, and served as Senior Vice President, Chief Financial Officer and Treasurer from January 2018 to May 2018. Ms. Vosseller is our principal financial and accounting officer. She joined us as Vice President of Finance in 2013 and was promoted to Senior Vice President of Finance in August 2017. Prior to that time, she served as Vice President and Chief Financial Officer at Genoptix, beginning in 2011, after initially joining Genoptix in 2008. Prior to that she held a senior finance position at Biosite where she played a key role in developing the financial and administrative infrastructure for international expansion. Ms. Vosseller is a certified public accountant (inactive) and holds a BS in Accounting from Missouri State University.

What is Leigh Vosseller's net worth?

The estimated net worth of Leigh Vosseller is at least $138,330.40 as of May 12th, 2023. Ms. Vosseller owns 5,660 shares of Tandem Diabetes Care stock worth more than $138,330 as of June 7th. This net worth evaluation does not reflect any other assets that Ms. Vosseller may own. Learn More about Leigh Vosseller's net worth.

What is Leigh Vosseller's salary?

As the CFO of Tandem Diabetes Care, Inc., Ms. Vosseller earned a total compensation package of $1,613,288.00 in 2021. Ms. Vosseller earned a salary of $424,360.00, stock awards of $424,312.00, options awards of $424,335.00, non-equity compensation of $339,403.00, and other compensation of $878.00. Learn More on Leigh Vosseller's salary.

How do I contact Leigh Vosseller?

The corporate mailing address for Ms. Vosseller and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Leigh Vosseller's contact information.

Has Leigh Vosseller been buying or selling shares of Tandem Diabetes Care?

Over the course of the past ninety days, Leigh Vosseller has bought $98,801.55 of Tandem Diabetes Care stock. Most recently, on Friday, May 12th, Leigh Vosseller bought 3,015 shares of Tandem Diabetes Care stock. The stock was acquired at an average cost of $32.77 per share, with a total value of $98,801.55. Following the completion of the transaction, the chief financial officer now directly owns 5,660 shares of the company's stock, valued at $185,478.20. Learn More on Leigh Vosseller's trading history.

Who are Tandem Diabetes Care's active insiders?

Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.

Are insiders buying or selling shares of Tandem Diabetes Care?

In the last twelve months, Tandem Diabetes Care insiders bought shares 2 times. They purchased a total of 13,015 shares worth more than $393,501.55. In the last twelve months, insiders at the medical device company sold shares 3 times. They sold a total of 30,097 shares worth more than $1,470,906.94. The most recent insider tranaction occured on May, 18th when Director Dick Allen bought 10,000 shares worth more than $294,700.00. Insiders at Tandem Diabetes Care own 2.5% of the company. Learn More about insider trades at Tandem Diabetes Care.

Information on this page was last updated on 5/18/2023.

Leigh Vosseller Insider Trading History at Tandem Diabetes Care

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2023Buy3,015$32.77$98,801.555,660View SEC Filing Icon  
5/9/2022Buy500$70.00$35,000.009,118View SEC Filing Icon  
5/6/2022Buy2,000$75.76$151,520.008,618View SEC Filing Icon  
11/3/2021Sell10,000$140.05$1,400,500.00View SEC Filing Icon  
10/14/2021Sell10,000$135.09$1,350,900.00View SEC Filing Icon  
10/12/2021Sell10,000$130.00$1,300,000.00View SEC Filing Icon  
9/15/2021Sell3,500$125.00$437,500.00View SEC Filing Icon  
9/13/2021Sell10,000$120.75$1,207,500.0016,145View SEC Filing Icon  
10/13/2020Sell10,000$120.87$1,208,700.0014,520View SEC Filing Icon  
7/31/2020Sell10,000$110.03$1,100,300.0014,520View SEC Filing Icon  
7/6/2020Sell10,000$105.04$1,050,400.0014,520View SEC Filing Icon  
7/2/2020Sell20,000$97.74$1,954,800.0014,520View SEC Filing Icon  
6/30/2020Sell10,000$95.04$950,400.0014,520View SEC Filing Icon  
5/7/2020Sell10,000$90.07$900,700.0013,265View SEC Filing Icon  
1/29/2020Sell10,000$75.93$759,300.0012,882View SEC Filing Icon  
11/25/2019Sell10,000$70.35$703,500.0013,265View SEC Filing Icon  
11/18/2019Sell10,000$65.41$654,100.0013,265View SEC Filing Icon  
5/16/2019Sell10,000$70.45$704,500.0012,009View SEC Filing Icon  
5/3/2019Sell10,000$65.14$651,400.0012,009View SEC Filing Icon  
See Full Table

Leigh Vosseller Buying and Selling Activity at Tandem Diabetes Care

This chart shows Leigh Vosseller's buying and selling at Tandem Diabetes Care by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tandem Diabetes Care Company Overview

Tandem Diabetes Care logo
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $24.44
Low: $23.70
High: $24.74

50 Day Range

MA: $34.83
Low: $24.25
High: $42.46

2 Week Range

Now: $24.44
Low: $23.70
High: $70.81


1,334,993 shs

Average Volume

1,269,519 shs

Market Capitalization

$1.58 billion

P/E Ratio


Dividend Yield